DQICX
Price
$30.83
Change
-$0.32 (-1.03%)
Updated
Jun 13 closing price
Net Assets
1.68B
VIVAX
Price
$67.64
Change
-$0.55 (-0.81%)
Updated
Jun 13 closing price
Net Assets
188.77B
Interact to see
Advertisement

DQICX vs VIVAX

Header iconDQICX vs VIVAX Comparison
Open Charts DQICX vs VIVAXBanner chart's image
BNY Mellon Equity Income Fund C
Price$30.83
Change-$0.32 (-1.03%)
VolumeN/A
Net Assets1.68B
Vanguard Value Index I
Price$67.64
Change-$0.55 (-0.81%)
VolumeN/A
Net Assets188.77B
DQICX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DQICX vs. VIVAX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DQICX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. DQICX (1.68B). VIVAX pays higher dividends than DQICX: VIVAX (2.16) vs DQICX (0.63). DQICX was incepted earlier than VIVAX: DQICX (19 years) vs VIVAX (33 years). DQICX (1.81) is less costly to investors than VIVAX (0.17). DQICX is a more actively managed with annual turnover of: 28.63 vs. VIVAX (9.00). DQICX has a lower initial minimum investment than VIVAX: DQICX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 8.01 vs. DQICX (3.88). DQICX return over 5 years is better than : 81.22 vs. VIVAX (72.56).
DQICXVIVAXDQICX / VIVAX
Total Expense Ratio1.780.171,047%
Annual Report Gross Expense Ratio1.810.171,065%
Fund Existence19 years33 years-
Gain YTD1.9522.41981%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.68B189B1%
Annual Yield % from dividends0.632.1629%
Returns for 1 year3.888.0148%
Returns for 3 years36.7932.20114%
Returns for 5 years81.2272.56112%
Returns for 10 years89.53103.5486%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECX1.58-0.01
-0.63%
ECARX Holdings
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
MNSB18.25-0.21
-1.14%
MainStreet Bancshares
MPW4.41-0.08
-1.78%
Medical Properties Trust
INDP0.32-0.01
-4.22%
Indaptus Therapeutics